New early CaPP3 results focus on a practical prevention question for people with Lynch syndrome: if aspirin helps reduce colorectal cancer risk, could a lower daily dose be effective while lowering side effects? Here’s what the study can (and can’t) tell us yet—and what to discuss with your Lynch care team.
Blistering sunburn is a sign of significant UV damage. Here’s the typical timeline, which symptoms mean you should get medical care, and what research says about future skin cancer risk.
In 2026, the American Cancer Society labeled blood-based colorectal cancer screening tests as “not preferred.” Here’s what that means for everyday decisions—what to ask if a clinic offers a blood test, and why a positive result still requires timely colonoscopy follow-up.
The American Cancer Society’s 2026 update adds a blood-based option for colorectal cancer screening in some average-risk adults. But colonoscopy and stool tests are still preferred, and a positive blood test still needs follow-up colonoscopy.
Medicare’s June 2026 coverage decision gives eligible average-risk adults another colorectal cancer screening option: a blood-based test every three years. But if the result is positive, a follow-up colonoscopy is still needed, and major cancer guidance still prefers colonoscopy or stool-based tests over blood tests.
A blood test is now included in American Cancer Society colorectal screening guidance, but for most average-risk adults, stool testing or colonoscopy still offers more proven screening value.
A self-collection option for HPV testing may make cervical cancer screening easier for some people in the United States. It does not replace follow-up care, and it is not a fit for everyone, but it may help reduce common barriers to screening.
A large U.S. trial is putting risk-based breast cancer screening in the spotlight. The main takeaway for readers: it looks promising, but it has not replaced current screening guidance, and people should not change their schedule on their own.
A January 2026 federal update makes HPV-only screening the preferred option for many women 30 to 65 and adds self-collection as a choice.
Blood in the urine is not always cancer, but new research suggests delayed follow-up is common. Here’s what hematuria means and when prompt care matters.
An oral cancer screening during a dental visit is usually a simple look-and-feel exam of the mouth, throat area, and neck. It can help spot suspicious changes early, even though current evidence still does not prove that screening symptom-free adults lowers deaths.
A new March 3, 2026 modeling study suggests breast MRI may make the most sense for people with extremely dense breasts plus higher-than-average breast cancer risk. A dense-breast notice alone does not automatically mean you need an MRI.
New 2026 U.S. colorectal cancer statistics show a split trend: rates keep falling in many older adults but are rising in younger adults. Here is what that means for symptoms, screening at 45, family history, and why access still matters.
The FDA says promotional materials for Anktiva gave a misleading picture of what the bladder cancer drug can treat and how it is used. Here is what the drug is actually approved for, who it may fit, how it is given, and why the study behind the approval matters.
A new federal update says self-collected HPV testing should be offered as an option for average-risk women ages 30 to 65. Here’s what changed, what did not, and why many insurance plans may not have to cover the new option with no out-of-pocket costs until plan years that start in 2027.
Blood in the urine can be caused by many conditions, from infections to kidney stones. But painless bleeding is also the most common early sign of bladder cancer. Here’s what U.S. guidelines say about screening, who is at higher risk, and when to seek care.
The U.S. Preventive Services Task Force now recommends that most women start mammograms at age 40 instead of 50. Here’s what changed, what the evidence shows, and what it means for your health and insurance coverage.
If you are 50 to 80 years old and have a significant smoking history, you may qualify for annual low-dose CT lung cancer screening. Here’s what the current U.S. guidelines say about eligibility, benefits, risks, and insurance coverage.
The FDA continues to monitor rare cancers linked to breast implants, including BIA-ALCL and emerging reports of BIA-SCC. Here’s what patients need to know about symptoms, risk levels, informed consent, and insurance coverage.
As spring and summer approach, federal health agencies are reminding Americans that skin cancer is largely preventable. Here’s what the CDC, FDA, USPSTF, and National Cancer Institute say about UV exposure, sunscreen safety, and who should take extra precautions.
If you’re 50 to 80 and have a significant smoking history, you may qualify for annual low-dose CT lung cancer screening. Here’s what the evidence shows, who is eligible, what the trade-offs are, and how insurance coverage works in 2026.
Colorectal cancer screening now starts at age 45 for most adults. Here’s what current U.S. guidelines say, how stool tests compare with colonoscopy, what happens after a positive result, and what insurance and Medicare typically cover.
End of content
End of content
